Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

Danielle B. P. Eekers*, Erik Roelofs, Macarena Cubillos-Mesias, Charles Niel, Robert Jan Smeenk, Ann Hoeben, Andre W. H. Minken, Marlies Granzier, Geert O. Janssens, Johannes H. A. M. Kaanders, Philippe Lambin, Esther G. C. Troost

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)57-65
Number of pages9
JournalActa Oncologica
Volume58
Issue number1
DOIs
Publication statusPublished - 2019

Keywords

  • HELICAL TOMOTHERAPY
  • BEAM THERAPY
  • ARC THERAPY
  • RADIOTHERAPY
  • RADIATION
  • CANCER
  • HEAD
  • PHOTONS
  • IMPACT
  • RANGE

Cite this

Eekers, D. B. P., Roelofs, E., Cubillos-Mesias, M., Niel, C., Smeenk, R. J., Hoeben, A., Minken, A. W. H., Granzier, M., Janssens, G. O., Kaanders, J. H. A. M., Lambin, P., & Troost, E. G. C. (2019). Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial. Acta Oncologica, 58(1), 57-65. https://doi.org/10.1080/0284186X.2018.1529424